MedTrace Logo

Ultrashape System in Combination With VelaShape II Device for Circumferential Reduction

NCT02154113 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2014-06-03

No results posted yet for this study

Summary

The purpose of this study is to compare the clinical performance of the Ultrashape system with VelaShape II device for reduction of the waist.

Conditions

  • Abdominal Fat

Interventions

DEVICE

Ultrashape

All subjects receive 3 successive Ultrashape treatments every two weeks in the anterior abdomen.

DEVICE

Velashape II

All subjects receive 3 successive Velashape treatments every two weeks in the anterior abdomen.

Sponsors & Collaborators

  • Syneron Medical

    lead INDUSTRY

Principal Investigators

  • Shlomit Mann · Syneron Medical Ltd.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-08-31
Completion
2013-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02154113 on ClinicalTrials.gov